Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 26% ± 8% | |
| classical monocyte | 3 studies | 22% ± 3% | |
| non-classical monocyte | 3 studies | 22% ± 6% | |
| dendritic cell | 3 studies | 28% ± 8% |
Insufficient scRNA-seq data for expression of ARAF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 4132.71 | 1445 / 1445 | 100% | 69.30 | 183 / 183 |
| liver | 100% | 4115.61 | 226 / 226 | 100% | 62.21 | 406 / 406 |
| ovary | 100% | 4782.93 | 180 / 180 | 100% | 86.78 | 430 / 430 |
| pancreas | 100% | 3700.66 | 328 / 328 | 100% | 74.07 | 178 / 178 |
| prostate | 100% | 5995.09 | 245 / 245 | 100% | 93.68 | 502 / 502 |
| uterus | 100% | 4845.60 | 170 / 170 | 100% | 71.91 | 459 / 459 |
| skin | 100% | 4156.49 | 1809 / 1809 | 100% | 65.25 | 471 / 472 |
| kidney | 100% | 5262.25 | 89 / 89 | 100% | 60.88 | 899 / 901 |
| lung | 100% | 5265.70 | 578 / 578 | 100% | 71.45 | 1152 / 1155 |
| thymus | 100% | 5513.79 | 653 / 653 | 100% | 70.74 | 603 / 605 |
| stomach | 100% | 4630.21 | 359 / 359 | 100% | 77.28 | 285 / 286 |
| intestine | 100% | 4956.70 | 966 / 966 | 100% | 80.08 | 525 / 527 |
| breast | 100% | 4744.73 | 459 / 459 | 99% | 74.61 | 1112 / 1118 |
| bladder | 100% | 4651.52 | 21 / 21 | 99% | 71.21 | 501 / 504 |
| adrenal gland | 100% | 5149.84 | 258 / 258 | 97% | 45.48 | 224 / 230 |
| brain | 95% | 1426.96 | 2509 / 2642 | 100% | 51.37 | 705 / 705 |
| adipose | 100% | 4736.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 53.39 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 82.42 | 29 / 29 |
| muscle | 100% | 7504.59 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6304.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 67.47 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.99 | 1 / 1 |
| blood vessel | 100% | 4887.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 5606.33 | 928 / 929 | 0% | 0 | 0 / 0 |
| heart | 99% | 3757.95 | 855 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
| GO_0032434 | Biological process | regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0036211 | Biological process | protein modification process |
| GO_0032006 | Biological process | regulation of TOR signaling |
| GO_0000165 | Biological process | MAPK cascade |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005829 | Cellular component | cytosol |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | ARAF |
| Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks) |
| Synonyms | hCG_29140 PKS2 PKS ARAF1 |
| Description | FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 . .; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. . |
| Accessions | Q96II5 ENST00000377045.9 [P10398-1] A0A024R178 ENST00000377039.2 [P10398-2] P10398 A0A0S2Z3F2 |